生物活性 | |||
---|---|---|---|
描述 | Besifovir (LB80331), transformed from LB80380, undergoes further metabolic conversion to its active derivative, LB80317. It is identified as an innovative, orally administered antiviral compound effective against the hepatitis B virus (HBV)[1].[2]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
3.34mL 0.67mL 0.33mL |
16.71mL 3.34mL 1.67mL |
33.42mL 6.68mL 3.34mL |
参考文献 |
---|